DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CANAGLIFLOZIN

« Back to Dashboard

All Clinical Trials for Canagliflozin

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00642278	An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 2	2008-04-01	The purpose of this study is to evaluate the effectiveness, safety, and tolerability of JNJ-28431754 compared with placebo in patients with type 2 diabetes.
NCT00650806	A Study of the Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have Diabetes	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 2	2008-05-01	The purpose of this study is to test the safety and effectiveness of JNJ-28431754 in promoting weight loss in patients who are overweight or obese and who do not have diabetes.
NCT00963768	A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 1	2007-06-01	The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (ie, blood levels of JNJ-28431754) and pharmacodynamics (ie, urine and blood levels of glucose) of JNJ-28431754 compared to placebo in patients with Type 2 diabetes mellitus.
NCT00968812	CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride	Completed	Janssen Research & Development, LLC	Phase 3	2009-09-01	The purpose of this study is to demonstrate the efficacy, safety, and tolerability of canagliflozin (JNJ-28431754) compared with glimepiride in patients with type 2 diabetes mellitus with inadequate control despite treatment with metformin.

Clinical Trial Conditions for Canagliflozin

Condition Name

Condition Name for Canagliflozin
Intervention	Trials
Healthy	40
Diabetes Mellitus, Type 2	35
Type 2 Diabetes Mellitus	12
Type 2 Diabetes	5

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Canagliflozin
Intervention	Trials
Diabetes Mellitus	58
Diabetes Mellitus, Type 2	55
Kidney Diseases	5
Diabetic Nephropathies	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Canagliflozin

Trials by Country

Trials by Country for Canagliflozin
Location	Trials
United States	511
Canada	60
Mexico	17
India	17
Germany	14

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Canagliflozin
Location	Trials
Florida	28
California	27
Arizona	24
Texas	24
Ohio	17

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Canagliflozin

Clinical Trial Phase

Clinical Trial Phase for Canagliflozin
Clinical Trial Phase	Trials
Phase 4	25
Phase 3	20
Phase 2	10

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Canagliflozin
Clinical Trial Phase	Trials
Completed	73
Recruiting	21
Not yet recruiting	16

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Canagliflozin

Sponsor Name

Sponsor Name for Canagliflozin
Sponsor	Trials
Janssen Research & Development, LLC	41
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	31
Janssen Scientific Affairs, LLC	8

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Canagliflozin
Sponsor	Trials
Industry	99
Other	40
NIH	3

Export unavailable in trial.
Subscribe for complete access.